Evidence map›Paper›PMID 38014537›Full record

ArticleCirculation. Genomic and precision medicine2023

Genotype-Phenotype Taxonomy of Hypertrophic Cardiomyopathy.

Lara Curran, Antonio de Marvao, Paolo Inglese, Kathryn A McGurk, Pierre-Raphaël Schiratti, Adam Clement, Sean L Zheng, Surui Li, Chee Jian Pua, Mit Shah and 18 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation. Genomic and precision medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 6 countries.

Lara Curran *National Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0003-1260-3741
Antonio de Marvao *Medical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).ORCID 0000-0001-9095-5887
Paolo Inglese *Medical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).ORCID 0000-0001-6179-9643
Kathryn A McGurkNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0002-5445-6906
Pierre-Raphaël SchirattiMedical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).
Adam ClementMedical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).ORCID 0000-0001-6073-1831
Sean L ZhengNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Surui LiBiomedical Image Analysis Group, Department of Computing (S.L., W.B.).
Chee Jian PuaNational Heart Research Institute Singapore, Singapore, PRC (C.J.P., C.W.L.C., S.A.C.).ORCID 0000-0003-4683-3043
Mit ShahMedical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).
Pantazis TheotokisNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0001-8718-230X
Rachel J BuchanNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Sean J JurgensDepartment of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands (S.J.J., C.R.B.).ORCID 0000-0002-1605-9782
Claire E RaphaelNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0002-2206-0413
Arun John BaksiNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Antonis PantazisNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Brian P HallidayNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Dudley J PennellNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0001-5523-1314
Wenjia BaiBiomedical Image Analysis Group, Department of Computing (S.L., W.B.).ORCID 0000-0003-2943-7698
Calvin W L ChinNational Heart Research Institute Singapore, Singapore, PRC (C.J.P., C.W.L.C., S.A.C.).
Rafik TadrosCardiovascular Genetics Centre, Montreal Heart Institute (R.T.).
Connie R BezzinaDepartment of Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam University Medical Centers, University of Amsterdam, the Netherlands (S.J.J., C.R.B.).ORCID 0000-0002-0633-3514
Hugh WatkinsRadcliffe Department of Medicine, University of Oxford, United Kingdom (H.W.).ORCID 0000-0002-5287-9016
Stuart A CookDepartment of Women and Children's Health (A.d.M.).ORCID 0000-0001-6628-194X
Sanjay K PrasadNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).ORCID 0000-0002-5637-0727
James S WareNational Heart and Lung Institute (L.C., K.A.M., S.L.Z., P.T., R.J.B., C.E.R., A.J.B., A.P., B.P.H., D.J.P., S.K.P., J.S.W.).
Declan P O'ReganMedical Research Council Laboratory of Medical Sciences, Imperial College London, United Kingdom (A.d.M., P.I., K.A.M., P.-R.S., A.C., S.L.Z., S.L., M.S., M.J., P.T., R.J.B., S.A.C., J.S.W., D.P.O.).
Lung Institute · USMedical Research Council · GBHarefield Hospital · GBNational Heart Foundation of Australia · AUNational University Heart Centre Singapore · SGAmsterdam University Medical Centers · NLBritish Heart Foundation · GBBroad Institute · USImperial College London · GBJohn Radcliffe Hospital · GBMayo Clinic · USMontreal Heart Institute · CARoyal Brompton & Harefield NHS Foundation Trust · GBWomen's and Children's Health Network · AU

Funding

British Heart Foundation BBC/F/21/220106British Heart Foundation FS/ICRF/21/26019British Heart Foundation FS/IPBSRF/22/27059British Heart Foundation RG/18/9/33887British Heart Foundation RG/19/6/34387Medical Research Council MC_U120085815Medical Research Council MC_UP_1102/19Medical Research Council MC_UP_1102/20Medical Research Council MC_UP_1605/13
6 · The paper itself

Abstract

backgroundHypertrophic cardiomyopathy (HCM) is an important cause of sudden cardiac death associated with heterogeneous phenotypes, but there is no systematic framework for classifying morphology or assessing associated risks. Here, we quantitatively survey genotype-phenotype associations in HCM to derive a data-driven taxonomy of disease expression.

methodsWe enrolled 436 patients with HCM (median age, 60 years; 28.8% women) with clinical, genetic, and imaging data. An independent cohort of 60 patients with HCM from Singapore (median age, 59 years; 11% women) and a reference population from the UK Biobank (n=16 691; mean age, 55 years; 52.5% women) were also recruited. We used machine learning to analyze the 3-dimensional structure of the left ventricle from cardiac magnetic resonance imaging and build a tree-based classification of HCM phenotypes. Genotype and mortality risk distributions were projected on the tree.

resultsCarriers of pathogenic or likely pathogenic variants for HCM had lower left ventricular mass, but greater basal septal hypertrophy, with reduced life span (mean follow-up, 9.9 years) compared with genotype negative individuals (hazard ratio, 2.66 [95% CI, 1.42-4.96];

conclusionsWe report a data-driven taxonomy of HCM for identifying groups of patients with similar morphology while preserving a continuum of disease severity, genetic risk, and outcomes. This approach will be of value in understanding the causes and consequences of disease diversity.

Indexed as

Cardiomyopathy, HypertrophicCardiomyopathy, Hypertrophic, FamilialFemaleGenotypeHumansHypertrophyMaleMiddle AgedPhenotypegenotypehypertensionhypertrophymagnetic resonance imagingphenotype

Identifiers

PMID38014537
PMCPMC10729901
OpenAlexW4389090039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.